BODY WEIGHT GAIN INHIBITOR

(19)

(11)

EP 1 579 872 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	07.11.2012 Bulletin 2012/45

(45)	Mention of the grant of the patent:
	28.03.2012 Bulletin 2012/13

(21)	Application number: 03768195.4

(22)	Date of filing: 25.12.2003

(51)

International Patent Classification (IPC):

A61K 31/4245^(2006.01)
A61K 45/00^(2006.01)

A61K 31/4439^(2006.01)
A61P 3/04^(2006.01)

(86)	International application number:
	PCT/JP2003/016656

(87)	International publication number:
	WO 2004/060399 (22.07.2004 Gazette 2004/30)

(54)	BODY WEIGHT GAIN INHIBITOR MITTEL ZUR HEMMUNG DER KÖRPERGEWICHTSZUNAHME INHIBITEUR DE PRISE DE POIDS CORPOREL

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30)

Priority:

27.12.2002 JP 2002380386

(43)	Date of publication of application:
	28.09.2005 Bulletin 2005/39

(73)	Proprietor: Takeda Pharmaceutical Company Limited
	Osaka-shi, Osaka 541-0045 (JP)

(72)	Inventors:
	TERASHITA, Zen-ichi Osaka-shi, Osaka 532-8686 (JP) KUSUMOTO, Keiji Osaka-shi, Osaka 532-8686 (JP) YAMAGUCHI, Fuminari Osaka-shi, Osaka 532-8686 (JP) IMURA, Yoshimi Osaka-shi, Osaka 532-8686 (JP)

(74)	Representative: König, Gregor Sebastian et al
	König Szynka Tilmann von Renesse Patentanwälte Partnerschaft Postfach 11 09 46 40509 Düsseldorf 40509 Düsseldorf (DE)

(56)

References cited: :

WO-A1-01/05428
WO-A1-01/60410
WO-A1-02/074340
WO-A1-03/047573
WO-A2-01/76574
JP-A- 11 043 474

WO-A1-01/60362
WO-A1-02/15935
WO-A1-03/013609
WO-A2-01/76573
WO-A2-02/15933

ORTLEPP JAN R ET AL: "Angiotensin II receptor antagonism and ACE inhibition ameliorate hyperinsulinemia and obesity in a murine model of polygenic obesity" JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 39, no. 5 Supplement A, 6 March 2002 (2002-03-06), page 232A, XP002362571 & 51ST ANNUAL SCIENTIFIC SESSION OF THE AMERICAN COLLEGE OF CARDIOLOGY; ATLANTA, GA, USA; MARCH 17-20, 2002 ISSN: 0735-1097
NODA M. ET AL: 'Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar fatty rats)' JPN J. PHARMACOL. vol. 85, no. 4, 2001, pages 416 - 422, XP002977899

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).